NEW YORK (TheStreet) -- RATINGS CHANGES
Achillion Pharmaceuticals (ACHN) was upgraded at William Blair to outperform. Twelve-month price target is $18. Company monetized its HCV franchise and will focus on Factor D, William Blair said.
Achillion Pharmaceuticals was downgraded at JMP Securities to market perform from market outperform. Twelve-month price target is $24. ACHN is reinventing itself by outsourcing HCV and focusing on preclinical assets, JMP Securities said. The analysts downgraded the stock as they believe the HCV franchise is fairly valued at current levels, JMP Securities also said.
Computer Sciences (CSC) was upgraded at Morgan Stanley to neutral from underweight. Twelve-month price target is $66. Business split should unlock shareholder value, Morgan Stanley said.
Express Scripts (ESRX) was initiated with a neutral rating at Robert Baird. Twelve-month price target is $94. Valuation call, given the company's lower growth potential, Robert Baird said.
Keurig Green Mountain (GMCR) was downgraded at Argus to hold from buy. Company is seeing lower sales and will likely face price competition, Argus said.
Lending Club (LC) was upgraded at Morgan Stanley to overweight from equal weight. Twelve-month price target is $23. Upgrading on account of its recent selloff, Morgan Stanley said. Recent competitive fears are overblown, and the online peer-to-peer lender's long-term growth potential is underestimated, Morgan Stanley said.